SPONSOR
The First Affiliated Hospital of Xiamen University
Total Trials
8
Recruiting
8
Phases
Phase 2, Phase 1
Conditions studied: Nephrotic SyndromeRituximabChildrenEfficacyNasopharyngeal Cancinoma (NPC)SBRTImmunotherapyAcute Myeloid LeukemiaRelapseRefractory AML
NCT06530004
Recruiting
Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children
Nephrotic Syndrome
NCT06676722 Phase 2
Recruiting
SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy
Nasopharyngeal Cancinoma (NPC)
NCT06651866 Phase 1
Recruiting
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
Acute Myeloid Leukemia
NCT06737523 Phase 1
Recruiting
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
Acute Myeloid Leukemia
NCT06375564 Phase 1
Recruiting
Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression
Refractory Solid Tumor
NCT03799653
Recruiting
A Nurse Cohort Study in Xiamen, China
Hypertension
NCT05841615
Recruiting
Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)
AF - Atrial Fibrillation
NCT06757023
Recruiting
A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
Postoperative Complications